Masahiro Nagai - Concepedia

Author

Masahiro Nagai

Also Known As

Coe Pl, M NAGAI, M Nagai, M. NAGAI, M. Nagai, MASAHIRO NAGAI, Machiko NAGAI, Masahiro NAGAI, Masahiro Nagai, Masahiro Nagai (9127836)

390

Publications

6.2K

Citations

H-Index

169

Concepts

All Affiliations

Ehime University Hoshi University Kagoshima University Ehime University Hospital Ebara (Japan)

About

Masahiro Nagai is an author at Ehime University specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	52	2.5K
2	Natural Sciences	18	25	671
3	Engineering	12	13	657
4	Health Sciences	2	2	42
5	Management	1	1	91

Masahiro Nagai

114

Publications

5.3K

Citations

H-Index

Page 1

	Year	Citations
Analysis Of Htlv-I Proviral Load In 202 Ham/Tsp Patients And 243 Asymptomatic Htlv-I Carriers: High Proviral Load Strongly Predisposes To Ham/Tsp Masahiro Nagai, Koichiro Usuku, Wataru Matsumoto, Journal of NeuroVirology Asymptomatic Htlv-i CarriersHtlv-i Proviral LoadViral PersistenceHuman RetrovirusImmunology	1998	695
HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy Katie Jeffery, Koichiro Usuku, Sarah E. Hall, Proceedings of the National Academy of Sciences	1999	423
Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8+ T cells, and disease severity in HTLV-1–associated myelopathy (HAM/TSP) Yoshihisa Yamano, Masahiro Nagai, Meghan Brennan, Blood	2002	279
Phosphate removal and recovery with a synthetic hydrotalcite as an adsorbent Kazumichi Kuzawa, Yong-Jun Jung, Yoshiaki Kiso, Chemosphere Environmental ChemistryChemical EngineeringEngineeringClay MineralEnvironmental Engineering	2005	255
CD8+ T cells are an in vivo reservoir for human T-cell lymphotropic virus type I Masahiro Nagai, Meghan Brennan, Jill A. Sakai, Blood	2001	161
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study David Adams, Michael Polydefkis, Alejandra González‐Duarte, The Lancet Neurology Alzheimer's DiseaseOpen-label Extension StudyMedicineHereditary Transthyretin-mediated AmyloidosisNeurology	2020	154
Antitumor Agents. Part 214:††For paper 213, see ref 1. Synthesis and Evaluation of Curcumin Analogues as Cytotoxic Agents Junko Ishida, Hironori Ohtsu, Yoko Tachibana, Bioorganic & Medicinal Chemistry Medicinal ChemistryPharmaceutical ChemistryAntitumor AgentsMedicinePharmacotherapy	2002	144
Increased HTLV‐I proviral load and preferential expansion of HTLV‐I tax‐specific CD8<sup>+</sup> T cells in cerebrospinal fluid from patients with HAM/TSP Masahiro Nagai, Yoshihisa Yamano, Meghan Brennan, Annals of Neurology Htlv‐i Proviral LoadViral DiagnosticsImmunodeficienciesImmunologyViral Pathogenesis	2001	142
Increased Activated Human T Cell Lymphotropic Virus Type I (HTLV‐I) Tax11‐19–Specific Memory and Effector CD8<sup>+</sup>Cells in Patients with HTLV‐I–Associated Myelopathy/Tropical Spastic Paraparesis: Correlation with HTLV‐I Provirus Load Masahiro Nagai, Ryuji Kubota, Tim F. Greten, The Journal of Infectious Diseases ImmunodeficienciesImmunologyImmunodominanceAntigen ProcessingCd4 T Cell Responses	2001	129
Bone Resorption Inhibitors from Hop Extract Hiroyasu Tobe, Yoshifumi Muraki, Kazuyuki Kitamura, Bioscience Biotechnology and Biochemistry	1997	109

Page 1